Extrovis

Extrovis company information, Employees & Contact Information

Explore related pages

Related company profiles:

Extrovis is a fully integrated global pharmaceutical company with strong portfolio offering, comprising of Active Pharmaceutical Ingredients (APIs), Finished dosage forms (FDF) & Custom Pharmaceutical Services. Based in Switzerland, with global presence in North America, India and South America, we are supported by strong network to deliver products across geographies. Our state-of-the-art manufacturing facilities and R&D centers comply with highest international quality standards with accreditions from the USFDA, PMDA, EU and other global regulatory bodies. Our contributions in the area of education and health to financially under privileged reinforces our social commitment. Our mission is to become a reliable partner by offering high quality APIs, FDFs, custom pharmaceutical services and delivering value to our customers, stake holders and patients. Backed by our EXTROrdinary VISion, we have our eyes set on becoming a leading pharmaceutical company in the world.

Company Details

Employees
215
Address
Zug, Zurich 6300, Ch
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Follow.
HQ
Zug, Zurich
Looking for a particular Extrovis employee's phone or email?

Extrovis Questions

News

Extrovis AG and Dr. Reddy’s announce the launch of the - GlobeNewswire

Extrovis AG and Dr. Reddy’s announce the launch of the GlobeNewswire

Extrovis AG and Dr Reddy’s launch authorised generic Fluorouracil Cream 0.5 per cent in US market - Express Pharma

Extrovis AG and Dr Reddy’s launch authorised generic Fluorouracil Cream 0.5 per cent in US market Express Pharma

Dr. Reddy's Expands U.S. Generic Portfolio with Carac 0.5% Authorized Generic Launch - scanx.trade

Dr. Reddy's Expands U.S. Generic Portfolio with Carac 0.5% Authorized Generic Launch scanx.trade

Megasoft to divest 36.5% in Swiss arm Extrovis AG for $15 mn - BusinessLine

Megasoft to divest 36.5% in Swiss arm Extrovis AG for $15 mn BusinessLine

Megasoft Limited Reports Stellar Q1 Results with Rs 13,643.55 Crore Net Profit - scanx.trade

Megasoft Limited Reports Stellar Q1 Results with Rs 13,643.55 Crore Net Profit scanx.trade

Dr. Reddy’s and Extrovis Launch Generic Fluorouracil Cream in U.S. - The Indian Awaaz

Dr. Reddy’s and Extrovis Launch Generic Fluorouracil Cream in U.S. The Indian Awaaz

Top Extrovis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant